18/12/2023 | Share Purchase Plan Offer |
18/12/2023 | Cleansing Notice – SPP |
11/12/2023 | Investor Webinar |
11/12/2023 | Appendix 3B |
11/12/2023 | Notice of EGM |
11/12/2023 | Share Purchase Plan |
11/12/2023 | Minimum Holding Buy-Back |
11/12/2023 | Delisting Announcement |
07/12/2023 | Trading Halt |
17/11/2023 | Results of Meeting AGM 2023 |
17/11/2023 | CEO Presentation to AGM November 2023 |
17/11/2023 | Chairman’s address to Shareholders 2023 AGM |
17/11/2023 | App 3Z BS |
27/10/2023 | Corporate Governance Statement |
27/10/2023 | Appendix 4G |
24/10/2023 | Rhinomed operational review |
20/10/2023 | Update on AGM and impending Board change |
19/10/2023 | Rhinoswab Program Update |
18/10/2023 | Annual Report to Shareholders 2023 |
18/10/2023 | Notice of Annual General Meeting & Proxy Form 2023 |
16/10/2023 | Retirement of Director |
07/09/2023 | Appendix 3Y JMcB |
08/08/2023 | Patent award in USA |
18/05/2023 | Change in substantial holding WG |
04/05/2023 | App 3Y MJ |
31/03/2023 | Change in substantial holding WG |
27/01/2023 | Canadian Market Update |
24/01/2023 | Executive Remuneration Review |